Today provided an update on the timing of its Premarket Approval submission to the U.S. Food and Drug Administration for its hemoadsorption device to treat endotoxic septic shock. Spectral Medical Inc shares T.EDT are trading down $0.03 at $1.36.
Stocks in play: Spectral Medical Inc
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here